Comment on “Toxic epidermal necrolysis during camrelizumab treatment for oesophageal squamous cell carcinoma”

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Contact dermatitis 2022-10, Vol.87 (4), p.387-388
Hauptverfasser:	Ruan, Yeping, Shih, Yanting, Chen, Shile, Xia, Qunli, Zhao, Xiaoqing, Cao, Hua
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibodies, Monoclonal, Humanized anti‐PD1 immunotherapy anti‐SSA antibody Dermatitis, Allergic Contact Esophageal Neoplasms - drug therapy Esophageal Squamous Cell Carcinoma - drug therapy Humans immune checkpoint inhibitors Monoclonal antibodies Ro‐52 Squamous cell carcinoma Stevens-Johnson Syndrome - etiology Toxic epidermal necrolysis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!